FDA Approves Multiple Sclerosis Stem Cell Trial – American News Report
| American News Report The new regenerative strategy will involve using mesenchymal stem cell-derived neural progenitor cells (MSC-NPs), which will be harvested from the bone marrow of MS patients. The stem cells will then be injected into the cerebrospinal fluid that … Studies from Technical University Further Understanding of Stem CellsHispanicBusiness.com Good News Watch: Stem Cells and Small Cap Stem Cell Stocks (NBS, ISCO …SmallCap Network |
